Skip to content

Released Mar 1, 2013, during market hours

10-K filed Mar 1, 2013, 60 days after period end · 0001193125-13-087561

Q4 2012 · 10-K
Revenue$115.61M−2.6% vs Q4 2011+9.3% vs Q3 2012
Net Income$22.95M+191.0% vs Q4 2011+512.6% vs Q3 2012
EPS Diluted$1.17+178.6% vs Q4 2011+515.8% vs Q3 2012
Gross Profit$88,856,000−2.7%
Operating Income$26,518,000+224.4%
Operating Cash Flowderived-$58,233,000N/M
Free Cash Flowderived-$68,015,000N/M
Margins · derived
Gross margin76.9%−0.1 pt vs Q4 2011
Operating margin22.9%+16.0 pt vs Q4 2011
Net margin19.9%+13.2 pt vs Q4 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2012Q4 2011Q4 2010
Revenue$115.61M$118.64M$143.80M
Net Income$22.95M$7.89M$7.96M
EPS Diluted$1.17$0.42$0.44

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR